TaiMed Biologics (4147.TWO) Earnings Analysis
TaiMed Biologics (4147.TWO) next reports earnings on 2026-08-07, consensus EPS -0.23 TWD. Last quarter (2026-03-03) it beat with EPS -0.25 TWD vs -0.28 TWD est (+10.7%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -128.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4147.TWO next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | -0.23 TWD |
| Revenue estimate | 0.16B |
4147.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | -0.25 TWD | -0.28 TWD | +10.7% | Beat |
| 2025-08-07 | -0.22 TWD | -0.24333 TWD | +9.6% | Beat |
| 2025-03-05 | -0.44 TWD | -0.17 TWD | -158.8% | Miss |
| 2024-11-08 | -0.14 TWD | -0.17 TWD | +17.6% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
4147.TWO valuation and analyst view
| Trailing P/E | -128.26 |
|---|---|
| Trailing EPS | -0.46094 TWD |
| Price / book | 4.23 |
| Dividend yield | 0.00% |
| Market cap | 15.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is TaiMed Biologics (4147.TWO)'s next earnings date?
TaiMed Biologics is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.23 TWD and revenue estimate of 0.16B.
Did 4147.TWO beat earnings last quarter?
In its 2026-03-03 report, 4147.TWO posted EPS of -0.25 TWD versus a -0.28 TWD estimate — a beat of 10.7%.
What is 4147.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 4147.TWO beat estimates 3 times (75%).
What is 4147.TWO's current P/E ratio and EPS?
4147.TWO trades at a trailing P/E of -128.26 on trailing EPS of -0.4609423445968011 TWD.
What do analysts rate 4147.TWO?
4147.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.